Insider selling
Traded Nov 10 · filed the same day
A Becton Dickinson officer told the SEC about a plan to sell $397K of Becton Dickinson shares around Nov 10, 2026. The shares were not acquired as compensation.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BDX · NYSE · Health Care Equipment
$216.08+0.66 (+0.31%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
Becton Dickinson (BDX) · oqro.io/stocks/BDX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
72 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider selling
Traded Nov 10 · filed the same day
A Becton Dickinson officer told the SEC about a plan to sell $397K of Becton Dickinson shares around Nov 10, 2026. The shares were not acquired as compensation.
Thomas E Jr Polen (Chairman, CEO and President) sold ~$629K of Becton Dickinson
Planned saleThomas Polen (Officer) plans to sell ~$626K of Becton Dickinson
Planned, from payMichael Feld (EVP, Chief Revenue Officer) sold ~$15K of Becton Dickinson
Planned saleMichael Feld (Officer) plans to sell ~$15K of Becton Dickinson
Planned, from payInsider selling
Traded Sep 28 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade +17.5% · S&P 500 −4.6% · to Nov 18
Becton Dickinson's Chief Revenue Officer sold $14K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Michael Feld (Officer) plans to sell ~$14K of Becton Dickinson
Planned, from payInsider selling
Traded Aug 26 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +13.6% · S&P 500 −4.7% · to Nov 18
Becton Dickinson's Chief Revenue Officer sold $31K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Aug 13 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +18.7% · S&P 500 −6.1% · to Nov 18
The CEO of Becton Dickinson sold $768K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Aug 11 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +19.1% · S&P 500 −5.2% · to Nov 18
Becton Dickinson's and President, EMEA sold $441K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Jul 27 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +36.0% · S&P 500 −1.2% · to Nov 18
Becton Dickinson's Chief Revenue Officer sold $12K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Jun 26 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +38.6% · S&P 500 +0.2% · to Nov 18
Becton Dickinson's Chief Revenue Officer sold $11K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Jun 24 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +46.2% · S&P 500 −0.4% · to Nov 18
Becton Dickinson's & Pres Med.Essntl&BioPharm sold $160K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Michael David Garrison (EVP & Pres Med.Essntl&BioPharm) sold ~$167K of Becton Dickinson
Automatic saleThomas E Jr Polen (Chairman, CEO and President) sold ~$405K of Becton Dickinson
Automatic saleInsider selling
Traded May 26 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +46.3% · S&P 500 −2.7% · to Nov 18
Becton Dickinson's Chief Revenue Officer sold $11K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Apr 27 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +43.8% · S&P 500 +2.1% · to Nov 18
Becton Dickinson's Chief Revenue Officer sold $11K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Michael Feld (EVP, Chief Revenue Officer) sold ~$12K of Becton Dickinson
Planned saleMichael Feld (EVP, Chief Revenue Officer) sold ~$14K of Becton Dickinson
Automatic saleInsider selling
Traded Feb 18 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade +18.3% · S&P 500 +6.4% · to Nov 18
A Becton Dickinson director sold $174K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Jan 26 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade +6.2% · S&P 500 +5.4% · to Nov 18
Becton Dickinson's CRO & Pres. Life Sciences sold $15K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Traded Jan 15, 2026 · largest single transaction ~$209KNot reported under a pre-arranged trading plan
Jan 15, 2026~$209K · 1,010 sh @ $206.54
DetailsInsider selling
Traded Dec 26, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
Since the trade +10.1% · S&P 500 +5.8% · to Nov 18
Becton Dickinson's CRO & Pres. Life Sciences sold $15K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Dec 17, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +10.6% · S&P 500 +8.8% · to Nov 18
Becton Dickinson's & Pres Med.Essntl&BioPharm sold $123K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Dec 1, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +12.7% · S&P 500 +7.3% · to Nov 18
Becton Dickinson's CRO & Pres. Life Sciences sold $15K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 7, 2025 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade +21.5% · S&P 500 +8.8% · to Nov 18
A Becton Dickinson director sold $38K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Oct 27, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +15.5% · S&P 500 +6.6% · to Nov 18
Becton Dickinson's & President, Life Sciences sold $11K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Michael Feld (EVP & President, Life Sciences) sold ~$10K of Becton Dickinson
Planned saleInsider selling
Traded Sep 10, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +14.7% · S&P 500 +12.0% · to Nov 18
A Becton Dickinson director sold $172K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Michael Feld (EVP & President, Life Sciences) sold ~$11K of Becton Dickinson
Planned saleInsider buying
Traded Aug 11, 2025 · filed the same day
Since the trade +12.3% · S&P 500 +14.8% · to Nov 18
A Becton Dickinson director paid $1.01M out of pocket for Becton Dickinson shares. Shares held went up 660% with this purchase.
Insider selling
Traded Aug 8, 2025 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade +11.7% · S&P 500 +14.6% · to Nov 18
A Becton Dickinson director sold $166K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Michael David Garrison (EVP & President, Medical) sold ~$213K of Becton Dickinson
Planned saleMichael David Garrison (EVP & President, Medical) sold ~$182 of Becton Dickinson
Planned saleDavid Shan (EVP and Chief ISC Officer) sold ~$200K of Becton Dickinson
Planned saleMichael David Garrison (EVP & President, Medical) sold ~$94K of Becton Dickinson
Planned saleRichard Byrd (EVP & President Interventional) sold ~$106K of Becton Dickinson
Planned saleRichard Byrd (EVP & President Interventional) sold ~$436K of Becton Dickinson
Planned saleInsider selling
Traded Feb 12, 2025 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −4.3% · S&P 500 +21.0% · to Nov 18
A Becton Dickinson director sold $160K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Jan 15, 2026~$125K · 600 sh @ $209.00
DetailsOfficial record0 open-market purchases and 14 open-market sales by insiders of BDX between Mar 3, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026. The data provider lists the next release for Feb 8, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 5, 2026 | 1 sale | 1 sale | None |
| Aug 6, 2026 | 1 sale | None | 3 sales |
| May 7, 2026 | 1 sale | None | 2 sales |
| Apr 2, 2026 | 1 sale | None | 1 sale |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies